Molecular Templates, Inc. (MTEMQ)
OTCMKTS
· Delayed Price · Currency is USD
0.00
0.00 (0.00%)
May 16, 2025, 4:00 PM EDT
Molecular Templates Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2015 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2015 - 2018 |
| Revenue | 57.31 | 19.75 | 38.7 | 18.85 | 22.27 | Upgrade
|
| Revenue Growth (YoY) | 190.10% | -48.95% | 105.34% | -15.38% | 67.63% | Upgrade
|
| Cost of Revenue | 48.88 | 82.43 | 84.67 | 92.97 | 50.52 | Upgrade
|
| Gross Profit | 8.43 | -62.67 | -45.97 | -74.12 | -28.25 | Upgrade
|
| Selling, General & Admin | 18.9 | 25.77 | 33.51 | 26.72 | 20.08 | Upgrade
|
| Operating Expenses | 18.9 | 25.77 | 33.51 | 26.72 | 20.08 | Upgrade
|
| Operating Income | -10.47 | -88.44 | -79.47 | -100.84 | -48.33 | Upgrade
|
| Interest Expense | -2.65 | -4.72 | -3.37 | -1.71 | -1.3 | Upgrade
|
| Interest & Investment Income | 1.21 | 0.99 | 0.43 | 1.03 | 2.32 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 0 | Upgrade
|
| EBT Excluding Unusual Items | -11.91 | -92.17 | -82.41 | -101.52 | -47.3 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.48 | -0.07 | - | -2.16 | - | Upgrade
|
| Asset Writedown | - | -0.43 | -0.6 | - | - | Upgrade
|
| Other Unusual Items | 4.25 | - | - | -1.24 | - | Upgrade
|
| Pretax Income | -8.14 | -92.67 | -83.01 | -104.91 | -69.42 | Upgrade
|
| Income Tax Expense | -0.01 | 0.05 | - | 0.01 | - | Upgrade
|
| Net Income | -8.12 | -92.72 | -83.01 | -104.92 | -69.42 | Upgrade
|
| Net Income to Common | -8.12 | -92.72 | -83.01 | -104.92 | -69.42 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 4 | 4 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 4 | 4 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | 19.85% | 1.87% | 16.16% | 26.03% | 27.59% | Upgrade
|
| EPS (Basic) | -1.80 | -24.69 | -22.52 | -33.06 | -27.57 | Upgrade
|
| EPS (Diluted) | -1.80 | -24.69 | -22.52 | -33.06 | -27.57 | Upgrade
|
| Free Cash Flow | -42.02 | -92.22 | -34.38 | -91.19 | -34.89 | Upgrade
|
| Free Cash Flow Per Share | -9.34 | -24.56 | -9.33 | -28.73 | -13.86 | Upgrade
|
| Gross Margin | 14.71% | - | -118.79% | - | -126.85% | Upgrade
|
| Operating Margin | -18.26% | -447.71% | -205.38% | -535.11% | -217.00% | Upgrade
|
| Profit Margin | -14.18% | -469.36% | -214.51% | -556.73% | -311.72% | Upgrade
|
| Free Cash Flow Margin | -73.33% | -466.85% | -88.85% | -483.89% | -156.68% | Upgrade
|
| EBITDA | -3.71 | -80.93 | -72.71 | -96.8 | -47.07 | Upgrade
|
| EBITDA Margin | -6.47% | - | -187.89% | - | -211.37% | Upgrade
|
| D&A For EBITDA | 6.76 | 7.51 | 6.77 | 4.04 | 1.25 | Upgrade
|
| EBIT | -10.47 | -88.44 | -79.47 | -100.84 | -48.33 | Upgrade
|
| EBIT Margin | -18.26% | - | -205.38% | - | -217.00% | Upgrade
|
| Revenue as Reported | 57.31 | 19.75 | 38.7 | 18.85 | 22.27 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.